About us

An independent pharmaceutical laboratory with an international outlook

Taha Pharma is a laboratory founded in February 2010, specialising in the manufacture of medicines for human use, with a focus on new generics and essential medicines.

Taha Pharma quality control laboratory

Who we are

Patients’ health as our priority

Taha Pharma aims to secure new operating patents and operates a 4,000 m² plant designed to European standards and FDA guidelines.

The laboratory set up its own research and development department, distinguished by its bioequivalence studies, to develop products that meet very strict quality criteria for the benefit of the local and international community.

Our vision

An independent, responsible industrial laboratory with an international outlook, founded on the following principles:

  • A dynamic organisation that fosters employee motivation.
  • Sharing our expertise with our partners, in Tunisia and internationally.
  • Making patients’ health our priority, protecting the environment and ensuring the safety of our staff.
  • Being recognised for the quality of our products.

Our mission

To provide patients with suitable products that meet quality standards.

Thanks to a dynamic research team and its sense of responsibility towards patients, we guarantee strict hygiene standards and all the necessary quality control procedures.

Taha Pharma is also committed to national and regional public health policies, notably in the management of chronic diseases such as viral hepatitis B and C.

Milestones

Key milestones

  1. 2010Taha Pharma Laboratories founded (February 2010).
  2. 2014Opening of the Medjez El Bab plant (Béja governorate): 4,000 m² designed to European standards.
  3. 2015 – 2017Five invention patents filed with INNORPI.
  4. 2016ISO 9001:2015 certification (TÜV Rheinland) and ISO/IEC 17025 accreditation of the microbiology laboratory (TUNAC).
  5. 2018GMP certificate issued by INFARMED (Portugal) and site registration by the Gulf Health Council.
  6. 2019Establishment registration with the U.S. FDA.